Antibody Drug Conjugate (ADC)

In this case study, Frontage develops a multiplexed LC-MS/MS assay that generates multiple PK profiles from one single sample preparation, saving sample volume, significantly increasing the assay throughput, and reducing costs.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Phone

This field is for validation purposes and should be left unchanged.

Antibody Drug Conjugate (ADC)

Resources to Consider

Bioanalytical Strategies for PK Analysis of Antibody-Drug Conjugates...

Bioanalysis of antibody-drug conjugates (ADCs) by LC/MS: challenges...

ADC Bioanalytical Strategies for PK Analysis of Antibody Drug...

Characterization of Interchain Cysteine Linked Antibody Drug...

Accurate Determination Of Drug-To-Antibody Ratio Of Interchain…

Simultaneous Quantification Of Total Antibody And...

Development of a Neutralizing Antibody Assay to support Clinical...

Hepatitis A Virus Infection In Cynomolgus Monkeys Confounds The...

Cost Effective and Efficient Progression of Lead Drug Candidates to...

Development of Stable Nanoemulsion Formulation as an Ophthalmic Drug...

Challenges of Global Drug Development

Validation of a 384 gene hybridization capture-based pharmacogenomics...